VI

VIRAGEN INC

  • CIK: 0000353482
  • EIN: 59-2101668
  • Business address: 865 SW 78TH AVENUE, SUITE 100, PLANTATION, Florida, 33324

Information

  • Mailing address
    865 SW 78TH AVENUE, SUITE 100, PLANTATION, Delaware, 33324
  • Phone
    9542338746
  • State location
    Florida
  • State of incorporation
    Delaware
  • Fiscal year end
    June 30
  • SIC
    2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Filings
    N/A

About VIRAGEN INC

VIRAGEN INC (CIK: 0000353482) is an American company incorporated in the state of Florida. Head office is located at 865 SW 78TH AVENUE, SUITE 100, PLANTATION, Florida, 33324. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). VIRAGEN INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
BERMAN NEIL 0001277011 Apr-23-2007 other: INVESTOR
Satellite Strategic Finance Associates, LLC 0001395037 Mar-20-2007 10 percent owner
ALEXANDRA INVESTMENT MANAGEMENT LLC 0001026736 Mar-19-2007 10 percent owner
ALEXANDRA GLOBAL MASTER FUND LTD 0001266087 Mar-19-2007 10 percent owner
Filimonov Mikhail 0001393983 Mar-19-2007 10 percent owner
BURKE NICHOLAS M 0001180611 Apr-07-2006 officer: Controller
SALISBURY ROBERT C 0001185468 Apr-07-2006 director
Speck Nancy A 0001317760 Apr-07-2006 director
RICE CHARLES A 0001285771 Jun-01-2004 director, officer: President & CEO
SINGER CARL N 0001181205 May-03-2004 director
POHLMAN RANDOLPH A 0001259764 Apr-30-2004 director
PERSSON PER ERIK 0001259990 Apr-30-2004 director
SIMONS CHARLES J 0001176527 Jan-09-2004 director
STAFFORD C RICHARD 0001240138 Jan-09-2004 director
ROTHBERG MELVIN 0001180623 Sep-03-2003 officer: Executive Vice President
KING BRYAN 0001217431 Jun-30-2003 other: Former Director. Resigned 6/03
HEALEY DENNIS W 0001178920 May-31-2003 director, officer: Executive Vice President, CFO
LIND DOUGLAS 0001181206 May-31-2003 director

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by VIRAGEN INC

Filings Format Description Filed/Effective File/Film Number
CT ORDER Document Acc-no: 9999999997-08-041623 (34 Act) Size: KB Oct-06-2008

001-15823

081109021
REVOKED Document Acc-no: 9999999997-12-009618 (34 Act) Size: KB Aug-25-2008

000-10252

12848311
25-NSE Document Acc-no: 0001143313-07-000192 (34 Act) Size: KB Nov-09-2007

001-15823
8-K Document

Current report filing

Acc-no: 0001193125-07-223868 (34 Act) Size: KB		 Oct-23-2007

001-15823

071185862
NT 10-K Document

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT

Acc-no: 0001193125-07-210110 (34 Act) Size: KB		 Sep-28-2007

001-15823

071143441
8-K Document

Current report filing

Acc-no: 0001193125-07-201548 (34 Act) Size: KB		 Sep-14-2007

001-15823

071118541
8-K Document

Current report filing

Acc-no: 0001193125-07-169329 (34 Act) Size: KB		 Aug-02-2007

001-15823

071020013
8-K Document

Current report filing

Acc-no: 0001193125-07-157433 (34 Act) Size: KB		 Jul-19-2007

001-15823

07987564
8-K Document

Current report filing

Acc-no: 0001193125-07-150968 (34 Act) Size: KB		 Jul-06-2007

001-15823

07967505
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001180611-07-000005 ( Act) Size: 0 KB		 Jul-02-2007

8-K Document

Current report filing

Acc-no: 0001193125-07-140078 (34 Act) Size: KB		 Jun-21-2007

001-15823

07934661
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0001193125-07-140060 (33 Act) Size: KB		 Jun-21-2007

333-143276

07934590
EFFECT Document Acc-no: 9999999995-07-002470 (33 Act) Size: KB Jun-20-2007

333-143276

07932513
8-K Document

Current report filing

Acc-no: 0001193125-07-136845 (34 Act) Size: KB		 Jun-15-2007

001-15823

07923921
S-8 Document

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Acc-no: 0001193125-07-124910 (33 Act) Size: KB		 May-29-2007

333-143340

07884535
S-3 Document

Registration statement for specified transactions by certain issuers

Acc-no: 0001193125-07-123493 (33 Act) Size: KB		 May-25-2007

333-143276

07880102
8-K Document

Current report filing

Acc-no: 0001193125-07-122439 (34 Act) Size: KB		 May-24-2007

001-15823

07876291
8-K Document

Current report filing

Acc-no: 0001193125-07-118829 (34 Act) Size: KB		 May-18-2007

001-15823

07865584
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001193125-07-115871 (34 Act) Size: KB		 May-15-2007

001-15823

07854931
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001180611-07-000003 ( Act) Size: 0 KB		 May-14-2007

Recent 20 filings. View all VIRAGEN INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Frequently Asked Questions

Tags:

  • VIRAGEN INC overview
  • VIRAGEN INC job
  • VIRAGEN INC stock
  • VIRAGEN INC ownership
  • VIRAGEN INC CEO
  • VIRAGEN INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Maze Therapeutics, Inc.
Update: Jan 08, 2025
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1375 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3856 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4303 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4717 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4836 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2312 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2349 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4497 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3681 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by